Jenny J Feng

6PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Infant and child healthNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2025
Clinical characteristics and treatment outcomes in multiple sclerosis patients treated with anti-CD20s who switched to fumarates: a retrospective analysis of a US healthcare claims database.

Aliza B Ben-Zacharia, Jenny J Feng, Brandon P Moss

|Apr 14, 2024
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.

Barry A Singer, Jenny Feng, Horacio Chiong-Rivero

|Dec 10, 2019
Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS).

Jenny Feng, Mary Rensel

|Nov 15, 2019
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation.

Laura E Baldassari, Sarah M Planchon, Robert A Bermel

|Oct 08, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting.

Laura E Baldassari, Jenny Feng, Gabrielle Macaron

|Jun 26, 2019
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.

Jenny Feng, Erik Offerman, Jian Lin

Pageof 1

Frequent Collaborators

3 joint publications

Sarah M Planchon

3 joint publications

Daniel Ontaneda

2 joint publications

Jeffrey A Cohen

2 joint publications

Laura E Baldassari